BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37963604)

  • 1. Rare blue-green urine due to excess indomethacin: A case report.
    Xu BP; Wang XT
    Nephrology (Carlton); 2024 Mar; 29(3):168-169. PubMed ID: 37963604
    [No Abstract]   [Full Text] [Related]  

  • 2. [The activity of blood and urinary enzymes in patients with osteoarthrosis deformans and a drug-induced kidney lesion during indomethacin treatment].
    Peklina GP; Zaritskaia LP
    Vrach Delo; 1990 Sep; (9):49-50. PubMed ID: 2284768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus.
    Andriessen P; Struis NC; Niemarkt H; Oetomo SB; Tanke RB; Van Overmeire B
    Acta Paediatr; 2009 May; 98(5):797-803. PubMed ID: 19187396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury.
    Kent AL; Brown L; Broom M; Broomfield A; Dahlstrom JE
    Pediatr Nephrol; 2012 Jul; 27(7):1111-7. PubMed ID: 22415583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal indomethacin toxicity in one member of monozygous twins; a case report.
    Demandt E; Legius E; Devlieger H; Lemmens F; Proesmans W; Eggermont E
    Eur J Obstet Gynecol Reprod Biol; 1990; 35(2-3):267-9. PubMed ID: 2335261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus.
    Yeh TF; Wilks A; Singh J; Betkerur M; Lilien L; Pildes RS
    J Pediatr; 1982 Sep; 101(3):433-7. PubMed ID: 7108667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
    Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
    Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does furosemide prevent changes in renal function induced by administration of indomethacin in premature infants?].
    Petion AM; Gouyon JB; Sandre D
    Arch Fr Pediatr; 1990 Oct; 47(8):615-6. PubMed ID: 2078116
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypocalcaemia and indomethacin.
    Cuneo R; Gilchrist N; Sainsbury R
    N Z Med J; 1986 Oct; 99(811):771-2. PubMed ID: 3464896
    [No Abstract]   [Full Text] [Related]  

  • 10. Maternal renal impairment after indomethacin tocolysis.
    Walker MP; Cantrell CJ
    J Perinatol; 1993; 13(6):461-3. PubMed ID: 8308589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of short-term indomethacin therapy on fetal urine output.
    Kirshon B; Moise KJ; Wasserstrum N; Ou CN; Huhta JC
    Obstet Gynecol; 1988 Jul; 72(1):51-3. PubMed ID: 3288929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts.
    Kushnir A; Pinheiro JM
    BMC Clin Pharmacol; 2011 Jun; 11():8. PubMed ID: 21718490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An extended study of indomethacin. I. Clinical pharmacology.
    Rothermich NO
    JAMA; 1966 Feb; 195(7):531-6. PubMed ID: 5216390
    [No Abstract]   [Full Text] [Related]  

  • 14. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
    Leonhardt A; Strehl R; Barth H; Seyberth HW
    Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.
    Monnens L; Jonkman A; Thomas C
    Clin Sci (Lond); 1984 Jun; 66(6):709-15. PubMed ID: 6723207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Side effects of indomethacin].
    Ayrolles C; Fournie A
    Therapie; 1976; 31(3):313-24. PubMed ID: 136764
    [No Abstract]   [Full Text] [Related]  

  • 17. Zinc prevents indomethacin-induced renal damage in rats by ameliorating oxidative stress and mitochondrial dysfunction.
    Varghese J; Faith M; Jacob M
    Eur J Pharmacol; 2009 Jul; 614(1-3):114-21. PubMed ID: 19445918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting oliguria following indomethacin for treatment of patent ductus arteriosus.
    Barrington KJ; Fox M
    Am J Perinatol; 1994 May; 11(3):220-2. PubMed ID: 8048989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term indomethacin therapy decreases fetal urine output and results in oligohydramnios.
    Kirshon B; Moise KJ; Mari G; Willis R
    Am J Perinatol; 1991 Mar; 8(2):86-8. PubMed ID: 2006947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper-indomethacin in rats.
    Bonin AM; Yáñez JA; Fukuda C; Teng XW; Dillon CT; Hambley TW; Lay PA; Davies NM
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):755-64. PubMed ID: 20035423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.